Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

Several compounds bearing the indolinone chemical scaffold are known to possess anticancer properties. For example, the tyrosine kinase inhibitor sunitinib is an arylideneindolin-2-one compound. The chemical versatility associated with structural modifications of indolinone compounds underlies the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaminska, Kamila K., Bertrand, Helene C., Tajima, Hisashi, Stafford, William C., Cheng, Qing, Chen, Wan, Wells, Geoffrey, Arner, Elias S.J., Chew, Eng-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130005/
https://www.ncbi.nlm.nih.gov/pubmed/27244886
http://dx.doi.org/10.18632/oncotarget.9579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130005/
https://www.ncbi.nlm.nih.gov/pubmed/27244886
http://dx.doi.org/10.18632/oncotarget.9579

Ejemplares similares